{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T16:03:54Z","timestamp":1769097834686,"version":"3.49.0"},"reference-count":38,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T00:00:00Z","timestamp":1674172800000},"content-version":"vor","delay-in-days":19,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Health Science Reports"],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background and Aims<\/jats:title><jats:p>It is unclear whether patients with previous intracerebral hemorrhage (ICH) should receive antithrombotic treatment to prevent ischemic events. We assessed stroke physicians' opinions about this, and their views on randomizing patients in trials assessing this question.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We conducted three web\u2010based surveys among stroke physicians in Scandinavia and the United Kingdom.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Eighty\u2010nine of 205 stroke physicians (43%) responded to the Scandinavian survey, 161 of 180 (89%) to the UK antiplatelet survey, and 153 of 289 (53%) to the UK anticoagulant survey. In Scandinavia, 19 (21%) stroke physicians were uncertain about antiplatelet treatment after ICH for ischemic stroke or transient ischemic attack (TIA) and 21 (24%) for prior myocardial infarction. In the United Kingdom, 116 (77%) were uncertain for ischemic stroke or TIA and 115 (717%) for ischemic heart disease. In Scandinavia, 32 (36%) were uncertain about anticoagulant treatment after ICH for atrial fibrillation, and 26 (29%) for recurrent deep vein thrombosis or pulmonary embolism. In the United Kingdom, 145 (95%) were uncertain about anticoagulants after ICH in at least some cases. In both regions combined, 191 of 250 (76%) would consider randomizing ICH survivors in a trial of starting versus avoiding antiplatelets, and 176 of 242 (73%) in a trial of starting versus avoiding anticoagulants.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Considerable proportions of stroke physicians in Scandinavia and the United Kingdom\u00a0were uncertain about antithrombotic treatment after ICH. A clear majority would consider randomizing patients in trials assessing this question. These findings support the need for such trials.<\/jats:p><\/jats:sec>","DOI":"10.1002\/hsr2.1059","type":"journal-article","created":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T12:45:20Z","timestamp":1674218720000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Antithrombotic treatment after intracerebral hemorrhage: Surveys among stroke physicians in Scandinavia and the United Kingdom"],"prefix":"10.1002","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6557-1064","authenticated-orcid":false,"given":"Elisabeth","family":"Forfang","sequence":"first","affiliation":[{"name":"Institute of Clinical Medicine University of Oslo Oslo Norway"},{"name":"Department of Geriatric Medicine Oslo University Hospital Oslo Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristin Tveitan","family":"Larsen","sequence":"additional","affiliation":[{"name":"Institute of Clinical Medicine University of Oslo Oslo Norway"},{"name":"Department of Geriatric Medicine Oslo University Hospital Oslo Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rustam Al\u2010Shahi","family":"Salman","sequence":"additional","affiliation":[{"name":"Centre for Clinical Brain Sciences University of Edinburgh Edinburgh UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon M.","family":"Bell","sequence":"additional","affiliation":[{"name":"Sheffield Institute for Translational Neuroscience University of Sheffield Sheffield UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Per","family":"Wester","sequence":"additional","affiliation":[{"name":"Department of Public Health and Clinical Science University of Ume\u00e5 Ume\u00e5 Sweden"},{"name":"Department of Clinical Science Karolinska Institutet Danderyds Hospital Stockholm Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eivind","family":"Berge","sequence":"additional","affiliation":[{"name":"Department of Cardiology Oslo University Hospital Oslo Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Torgeir Bruun","family":"Wyller","sequence":"additional","affiliation":[{"name":"Institute of Clinical Medicine University of Oslo Oslo Norway"},{"name":"Department of Geriatric Medicine Oslo University Hospital Oslo Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ole Morten","family":"R\u00f8nning","sequence":"additional","affiliation":[{"name":"Institute of Clinical Medicine University of Oslo Oslo Norway"},{"name":"Department of Neurology Akershus University Hospital Nordbyhagen Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2023,1,20]]},"reference":[{"key":"e_1_2_12_2_1","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.108.540112"},{"key":"e_1_2_12_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(07)70107-2"},{"key":"e_1_2_12_4_1","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.115.009087"},{"key":"e_1_2_12_5_1","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.114.006202"},{"key":"e_1_2_12_6_1","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.116.012945"},{"key":"e_1_2_12_7_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2013-306476"},{"key":"e_1_2_12_8_1","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.118.024449"},{"key":"e_1_2_12_9_1","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.110.589143"},{"key":"e_1_2_12_10_1","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.116.014643"},{"key":"e_1_2_12_11_1","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.116.016327"},{"key":"e_1_2_12_12_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-019672"},{"key":"e_1_2_12_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2017.11.009"},{"key":"e_1_2_12_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)30840-2"},{"key":"e_1_2_12_15_1","unstructured":"AssociationAS.International stroke conference: American stroke association2020.\u00a0https:\/\/www.abstractsonline.com\/pp8\/#!\/7927\/presentation\/5388"},{"key":"e_1_2_12_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(21)00264-7"},{"key":"e_1_2_12_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(21)00298-2"},{"key":"e_1_2_12_18_1","article-title":"Antithrombotic treatment after stroke due to intracerebral haemorrhage","volume":"5","author":"Perry LA","year":"2017","journal-title":"Cochrane Database of Sys\u00a0Rev"},{"key":"e_1_2_12_19_1","doi-asserted-by":"publisher","DOI":"10.1161\/STR.0000000000000069"},{"key":"e_1_2_12_20_1","doi-asserted-by":"publisher","DOI":"10.1177\/2396987319841187"},{"key":"e_1_2_12_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2011.08.017"},{"key":"e_1_2_12_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2011.03.034"},{"key":"e_1_2_12_23_1","doi-asserted-by":"publisher","DOI":"10.1177\/2396987320954671"},{"key":"e_1_2_12_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60768-5"},{"key":"e_1_2_12_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60941-7"},{"key":"e_1_2_12_26_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-018-2542-6"},{"key":"e_1_2_12_27_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0191137"},{"key":"e_1_2_12_28_1","doi-asserted-by":"publisher","DOI":"10.1177\/2396987319863606"},{"key":"e_1_2_12_29_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000004259"},{"key":"e_1_2_12_30_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.016261"},{"key":"e_1_2_12_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(19)30197-8"},{"key":"e_1_2_12_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2019.104351"},{"key":"e_1_2_12_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(19)30184-X"},{"key":"e_1_2_12_34_1","unstructured":"National Institute for Health Research.\u00a0National Institute for Health Research (NIHR) Stroke Research Network England National Institute for Health Research.2015.\u00a0https:\/\/www.nihr.ac.uk\/nihr-in-your-area\/stroke\/"},{"key":"e_1_2_12_35_1","unstructured":"Population Health Research Institute. EdoxabaN foR IntraCranial hemorrhage survivors with atrial fibrillation.2022.\u00a0https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03950076"},{"key":"e_1_2_12_36_1","unstructured":"Population Health Research Institute. The ASPIRE\u2010AF trial.2022.https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03968393"},{"key":"e_1_2_12_37_1","unstructured":"Imperial College London.\u00a0PREvention of STroke in intracerebral haemorrhaGE survivors with atrial fibrillation (PRESTIGE\u2010AF). PREvention of STroke in intracerebral haemorrhaGE survivors with atrial fibrillation (PRESTIGE\u2010AF).2022.\u00a0https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03996772"},{"key":"e_1_2_12_38_1","unstructured":"Avoiding anticoagulation after IntraCerebral haemorrhage.2022.https:\/\/ClinicalTrials.gov\/show\/NCT03243175"},{"key":"e_1_2_12_39_1","doi-asserted-by":"publisher","DOI":"10.4022\/jafib.1651"}],"updated-by":[{"DOI":"10.1002\/hsr2.1917","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,2,13]],"date-time":"2024-02-13T00:00:00Z","timestamp":1707782400000}}],"container-title":["Health Science Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hsr2.1059","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/hsr2.1059","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hsr2.1059","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T07:32:17Z","timestamp":1692862337000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/hsr2.1059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["10.1002\/hsr2.1059"],"URL":"https:\/\/doi.org\/10.1002\/hsr2.1059","archive":["Portico"],"relation":{"correction":[{"id-type":"doi","id":"10.1002\/hsr2.1917","asserted-by":"object"}]},"ISSN":["2398-8835","2398-8835"],"issn-type":[{"value":"2398-8835","type":"print"},{"value":"2398-8835","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"2022-09-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-03","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e1059"}}